| Literature DB >> 25012666 |
Sakae Maeda1, Hiroshi Wada2, Yoko Naito3, Hiroaki Nagano2, Szandor Simmons4, Yoshinori Kagawa1, Atsushi Naito1, Junichi Kikuta4, Taeko Ishii3, Yoshito Tomimaru2, Naoki Hama2, Koichi Kawamoto2, Shogo Kobayashi2, Hidetoshi Eguchi2, Koji Umeshita2, Hideshi Ishii2, Yuichiro Doki2, Masaki Mori5, Masaru Ishii6.
Abstract
Interferon-α (IFN-α) is used clinically to treat hepatocellular carcinoma (HCC), although the detailed therapeutic mechanisms remain elusive. In particular, IFN-α has long been implicated in control of the cell cycle, but its actual point of action has not been clarified. Here, using time lapse imaging analyses of the human HCC cell line HuH7 carrying a fluorescence ubiquitination-based cell cycle indicator (Fucci), we found that IFN-α induced cell cycle arrest in the G0/G1 phases, leading to apoptosis through an IFN-α type-2 receptor (IFNAR2)-dependent signaling pathway. Detailed analyses by time lapse imaging and biochemical assays demonstrated that the IFN-α/IFNAR2 axis sensitizes cells to apoptosis in the S/G2/M phases in preparation for cell death in the G0/G1 phases. In summary, this study is the first to demonstrate the detailed mechanism of IFN-α as an anticancer drug, using Fucci-based time lapse imaging, which will be informative for treating HCC with IFN-α in clinical practice.Entities:
Keywords: Apoptosis; Cell Cycle; Cell Death; Fucci; Hepatocellular Carcinoma; Interferon
Mesh:
Substances:
Year: 2014 PMID: 25012666 PMCID: PMC4156060 DOI: 10.1074/jbc.M114.551879
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157